Position in BLLN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$14,403,629
New position
Shares Held
182,463
first reported quarter
Ownership
0.397%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026VANGUARD CAPITAL MANAGEMENT LLC holds $38,476,447,490 across 42 Diagnostics & Research names. BLLN ranks #30 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
24,280,816 | $11,934,749,488 | |
| 2 | DHR |
Danaher Corp /De/
|
41,127,810 | $7,797,832,776 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
5,182,507 | $2,911,998,858 | |
| 4 | A |
Agilent Technologies, Inc.
|
18,381,030 | $2,095,069,799 | |
| 5 | WAT |
Waters Corp /De/
|
6,378,775 | $1,899,599,195 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
11,026,983 | $1,880,541,680 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
1,321,854 | $1,667,122,264 | |
| 8 | LH |
Labcorp Holdings Inc.
|
5,376,120 | $1,434,402,577 |
All Filings in BLLN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,403,629 | 182,463 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||